2016

Vitamin D deficiency drives type 2 diabetes and nerve damage, impacting over 75% of diabetic patients. This critical steroid hormone supports every cell, and low levels disrupt glucose metabolism, increasing risks beyond obesity. In 2025,…
Read More...

Metabolic syndrome, a cluster of risk factors, skyrockets your chances of heart disease, stroke, and diabetes. Alarmingly, a single junk food snack can trigger its onset, and nearly 35% of U.S. adults are affected, per a 2015 Journal of the…
Read More...

The medical industry insists diabetes is a life sentence, manageable only with drugs or insulin that raise risks of heart attack, nerve damage, and death. With over 100 million people worldwide, including 20 million Americans, facing type 2…
Read More...

Prescribed to over 100 million people worldwide, cholesterol medications like statins are marketed as “miracle” drugs to prevent heart disease. Yet, a Tulane University study reveals they act as cellular poisons, accelerating aging and…
Read More...

Are cancer cures being suppressed to protect a trillion-dollar industry? From Rick Simpson’s hemp oil to Dr. Burzynski’s clinical trials, evidence suggests pharmaceutical companies and regulatory bodies block effective, less toxic…
Read More...

Are cholesterol drugs like statins saving lives, or are they a billion-dollar scam? Over 40 million people worldwide take these medications, yet evidence suggests most gain no benefit while risking serious harm, including peripheral…
Read More...

Statin drugs, like Lipitor, Crestor, and Zocor, are prescribed to over 255 million Americans annually, costing $374 billion in 2014, yet they cause more harm than good. Marketed to lower “bad” cholesterol and prevent heart issues, statins…
Read More...

Medication-induced neuropathy has become a rising problem in the United States. A Mayo Clinic study revealed that 70% of Americans take prescription medications, with the average elderly person juggling over five daily. This epidemic of…
Read More...

In 2010, Americans spent nearly $19 billion on cholesterol-lowering statins, filling over 255 million prescriptions, making them the most prescribed drugs in the U.S., according to the IMS Institute for Healthcare Informatics. But are…
Read More...